glp 1 malnutrition is Common in Patients Utilizing Glucagon-Like Peptide-1 Agonists Prior to Total Joint Arthroplasty Seeing GLP-1 abuse on red

GLP-1 Agonists For Obesity Weight loss medications are approved for adults with obesity (BMI of 30 kg/m2 or more) or overweight (BMI of 27 kg/m2 or more) with a weight-related comorbidity, including high blood pressure, type 2 diabetes, or high cholesterol

For risks and side effects read the package insert and ask your doctor or at your pharmacy

Generally, one gram per kilogram (2.2 pounds) of body weight is recommended

doi: 10.1016/j.ijbiomac.2019.11.159 200 LiuPWangYYangGZhangQMengLXinYet al

Read More - 13 February 2026 Manila, Philippines On 12 February 2026, the Food and Drug Administration Philippines (FDA) and the Pharmaceuticals and Medical Devices